Literature DB >> 20599167

Low ejection fraction documented during cardiac catheterization is significantly associated with long-term, all-cause mortality.

Mohammad Reza Movahed1, Sudhakar Sattur.   

Abstract

BACKGROUND: Decreased ejection fraction (EF) has been found to be a strong predictor of mortality. However, this association has not been studied in patients undergoing ventriculography over a long period of time. Using a large database of patients who underwent coronary angiography for clinical reasons, we evaluated any association between severity of EF impairment and 10 year mortality.
METHODS: Retrospective angiographic data of 1,937 patients between 1993 to 1997 from the VA Long Beach Health Care System were studied. Decreased EF was defined as EF<50%. Using chi-square test and Cox survival analysis, we evaluated any association between decreased EF with mortality. Furthermore, we evaluated different degrees of decreased EF with all-cause mortality using uni- and multivariate analysis.
RESULTS: Total mortality was 22.9% of the cohort. Decreased EF was a strong predictor of death over a period of 10 years. (All-cause mortality occurred in 21.6 % of patients with normal EF vs. 41.7 %, OR 2.59, CI 2.06-3.26, P<.001). After adjustment for left main coronary artery disease, mitral regurgitation, three-vessel coronary disease, and clinical risk factors (diabetes, hypertension, hyperlipidemia, and smoking), decreased EF remained independently associated with all cause-mortality regardless of ethnicity.
CONCLUSION: Decreased EF measured during coronary angiography is a strong independent predictor of all-cause mortality over a period of 10 years.

Entities:  

Mesh:

Year:  2010        PMID: 20599167     DOI: 10.1016/j.carrev.2009.04.110

Source DB:  PubMed          Journal:  Cardiovasc Revasc Med        ISSN: 1878-0938


  1 in total

1.  The genetic basis for survivorship in coronary artery disease.

Authors:  Jennifer R Dungan; Elizabeth R Hauser; Xuejun Qin; William E Kraus
Journal:  Front Genet       Date:  2013-09-27       Impact factor: 4.599

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.